Cost-utility of injectable and oral GLP-1RAs for type 2 diabetes mellitus inadequately controlled with metformin: A Markov model analysis

Penglin Zhou, Rui Gao, Anan Li, Xichao Wu, Yanjiao Zhu, Shuai He, Yan Li, Rui Yang
Pharmacoeconomics and Policy · Elsevier · 2026-09-01 · DOI: 10.1016/j.pharp.2026.08.004

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles